芬瑞诺:第三代MRA及其对心血管健康的影响 - - 随机对照试验的见解
Michael Sabina1, Jennifer Trube1, Shrinand Shah1
1Lakeland Regional Health Medical Center, Lakeland, FL 33805, USA.
Journal of clinical medicine
|November 9, 2024
概括
费内伦是一种非类固醇矿物质皮质类受体对抗剂 (MRA),可改善慢性病和2型糖尿病患者的心血管和结局. 与传统的MRA相比,它提供了更高的安全性,副作用较少.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 矿物质皮质类受体抗剂 (MRA) 在控制心血管和脏疾病方面至关重要.
- 传统的类固醇MRAs,如螺旋和eplerenone携带高血和荷尔蒙副作用的风险.
- 芬瑞诺是一种新型的第三代非类固醇MRA,旨在提高选择性和安全性.
研究的目的:
- 审查Finerenone在治疗慢性病 (CKD) 和2型糖尿病 (T2D) 患者心血管结果中的疗效和安全性.
- 为了比较Finerenone的个人资料与传统的类固醇MRAs.
主要方法:
- 根据PRISMA指南进行了范围审查.
- 搜索包括随机对照试验 (RCT),后期分析和Finerenone心血管结果的元分析.
- 数据以叙事形式综合,评估研究质量.
主要成果:
- 芬瑞诺在减少心血管和脏事件方面显示出显著的益处.
- 与螺旋和埃普莱伦相比,它表现出更高的安全性概况,并将高卡莱米亚和荷尔蒙副作用降至最低.
- 有证据表明,Finerenone对于不耐受类固醇MRA的患者来说是一个有前途的替代品.
结论:
- 菲内伦代表了对CKD和T2D患者的MRA治疗的重大进展.
- 其增强的安全性和有效性支持其作为传统MRA的首选替代品的使用.
- 目前正在进行的试验将进一步确定其在各种心力衰竭表型中的作用.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Antihypertensive Drugs: Direct Renin Inhibitors
495
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
495
Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Exercise and Cardiovascular Response
739
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
739


